Tumor budding and E-cadherin expression are useful predictors of nodal involvement in T1 esophageal squamous cell carcinoma

Anticancer Research

Volumn 33, Issue 11, 2013, Pages 5023-5030

  Nakagawa, Yasuo ^a   Ohira, Masaichi ^a   Kubo, Naoshi ^a   Yamashita, Yoshito ^b   Sakurai, Katsunobu ^a   Toyokawa, Takahiro ^a   Tanaka, Hiroaki ^a   Muguruma, Kazuya ^a   Shibutani, Masatsune ^a   Yamazoe, Sadaaki ^a   Kimura, Kenjiro ^a   Nagahara, Hisashi ^a   Amano, Ryosuke ^a   Ohtani, Hiroshi ^a   Yashiro, Masakazu ^a   Maeda, Kiyoshi ^a   Hirakawa, Kosei ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA CITY GENERAL HOSPITAL   (Japan)

Author keywords

E cadherin; Nodal metastasis; T1 esophageal cancer; Tumor budding

Indexed keywords

UVOMORULIN; VASCULOTROPIN C;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; DISEASE FREE SURVIVAL; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS RESECTION; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPH VESSEL METASTASIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; ONCOLOGICAL PROCEDURE; PREDICTION; PRIMARY TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR BUDDING;

E-CADHERIN; NODAL METASTASIS; T1 ESOPHAGEAL CANCER; TUMOR BUDDING;

ADULT; AGED; CADHERINS; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR C;

EID: 84891369422     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Jemal A, Bray F and Center MM: Global cancer statistics. CA Cancer J Clin 61: 69-90, 2011.
2. Kodama M and Kakegawa T: Treatment of superficial cancer of the esophagus: a summary of responses to a questionnaire on superficial cancer of the esophagus in Japan. Surgery 123: 432-439, 1998.
3. Abunasra H, Lewis S and Beggs L: Predictors of operative death after oesophagectomy for carcinoma. Br J Surg 92: 1029-1033, 2005.
4. Law S, Wong KH and Kwok KF: Predictive factors for postoperative pulmonary complications and mortality after esophagectomy for cancer. Ann Surg 240: 791-800, 2004.
5. Machida H, Tominaga K and Minamino H: Locoregional mitomycin C injection for esophageal stricture after endoscopic submucosal dissection. Endoscopy 44: 622-625, 2012.
6. Sgourakis G, Gockel I and Lang H: Endoscopic and surgical resection of T1a/T1b esophageal neoplasms: A systematic review. World J Gastroenterol 19: 1424-1437, 2013.
7. Brown C, Howes B and Jamieson GG: Accuracy of PET-CT in predicting survival in patients with esophageal cancer. World J Surg 36: 1089-1095, 2012.
8. Yu W, Fu XL and Zhang YJ: A prospective evaluation of staging and target volume definition of lymph nodes by 18FDG PET/CT in patients with squamous cell carcinoma of thoracic esophagus. Int J Radiat Oncol Biol Phys 81: 759-765, 2011.
9. The Japan Esophageal Society. Guidelines for Clinical and Pathologic Studies on Carcinoma of the Esophagus, 10th ed. Tokyo, Japan: Kanehara & Co Ltd, 2007.
10. Sobin LH and Wittekind C: UICC TNM Classification of Malignant Tumors (6th edn). John Wiley & Sons: Hoboken, 2002.
11. Ueno H, Murphy J and Jass JR: Tumour 'budding' as an index to estimate the potential of aggressiveness in rectal cancer. Histopathology 40: 127-132, 2002.
12. Ueno H, Price AB and Wilkinson KH: A new prognostic staging system for rectal cancer. Ann Surg 240: 832-839, 2004.
13. Kazama S, Watanabe T and Ajioka Y: Tumour budding at the deepest invasive margin correlates with lymph node metastasis in submucosal colorectal cancer detected by anticytokeratin antibody CAM5.2. Br J Cancer 94: 293-298, 2006.
14. Ito E, Ozawa S and Kijima H: New invasive patterns as a prognostic factor for superficial esophageal cancer. J Gastroenterol 47: 1279-1289, 2012.
15. Nakanishi Y, Ohara M and Doumen H: Correlation between tumor budding and post-resection prognosis in patients with invasive squamous cell carcinoma of the thoracic esophagus. World J Surg 35: 349-356, 2011.
16. Teramoto H, Koike M and Tanaka C: Tumor budding as a useful prognostic marker in T1-stage squamous cell carcinoma of the esophagus. J Surg Oncol 108: 42-46, 2013.
17. Shiozaki H, Tahara H and Oka H: Expression of immunoreactive E-cadherin adhesion molecules in human cancers. Am J Pathol 139: 17-23, 1991.
18. Shiozaki H, Doki Y and Yamana H: A multi-institutional study of immunohistochemical investigation for the roles of cyclin D1 and E-cadherin in superficial squamous cell carcinoma of the esophagus. J Surg Oncol 79: 166-173, 2002.
19. Kalluri R and Weinberg RA: The basics of epithelial-mesenchymal transition. J Clin Invest 119: 1420-1428, 2009.
20. Zeisberg M and Neilson EG: Biomarkers for epithelial-mesenchymal transitions. J Clin Invest 119: 1429-1437, 2009.
21. Zlobec I, Lugli A and Baker K: Role of APAF-1, E-cadherin and peritumoral lymphocytic infiltration in tumour budding in colorectal cancer. J Pathol 212: 260-268, 2007.
22. Wang C, Huang H and Huang Z: Tumor budding correlates with poor prognosis and epithelial-mesenchymal transition in tongue squamous cell carcinoma. J Oral Pathol Med 40: 545-551, 2011.
23. Tanaka T, Ishiguro H and Kuwabara Y: Vascular endothelial growth factor C (VEGF-C) in esophageal cancer correlates with lymph node metastasis and poor patient prognosis. J Exp Clin Cancer Res 29: 83, 2010.
24. Okazawa T, Yoshida T and Shirai Y: Expression of vascular endothelial growth factor C is a prognostic indicator in esophageal cancer. Hepatogastroenterology 55: 1503-1508, 2008.
25. Tajima Y, Nakanishi Y and Ochiai A: Histopathologic findings predicting lymph node metastasis and prognosis of patients with superficial esophageal carcinoma: Analysis of 240 surgically resected tumors. Cancer 88: 1285-1293, 2000.
26. Eguchi T, Nakanishi Y and Shimoda T: Histopathological criteria for additional treatment after endoscopic mucosal resection for esophageal cancer: Analysis of 464 surgically resected cases. Mod Pathol 19: 475-480, 2006.
27. Koike M, Kodera Y and Itoh Y: Multivariate analysis of the pathologic features of esophageal squamous cell cancer: Tumor budding is a significant independent prognostic factor. Ann Surg Oncol 15: 1977-1982, 2008.
28. Miyata H, Yoshioka A and Yamasaki M: Tumor budding in tumor invasive front predicts prognosis and survival of patients with esophageal squamous cell carcinomas receiving neoadjuvant chemotherapy. Cancer 115: 3324-3334, 2009.